Clinical Trial Update: Randomized Controlled Trial of ImmuKnow in Liver Transplantation [NA]

View source ↗

Summary

A randomized controlled trial evaluating ImmuKnow to guide immunosuppression in liver transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• ImmuKnow

Snippet

Sponsor: University of Bologna | Conditions: Liver Disease | NA | Status: COMPLETED